Board Member
Cytek Biosciences, Inc. (CTKB)Equibles does not estimate personal net worth.
Get an email with a short summary when Cytek Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get CTKB alertsWenbin Jiang is recorded as Board Member and CEO at Cytek Biosciences, Inc. (CTKB). The newest filing on record that lists Wenbin Jiang as Board Member and CEO at Cytek Biosciences, Inc. (CTKB) is dated April 28, 2026. The proxy statement of Cytek Biosciences, Inc. reports total compensation of $5,120,061 for Wenbin Jiang in fiscal 2025, including a base salary of $620,000. Disclosed compensation is on record for 6 fiscal years. Wenbin Jiang has spoken on 17 earnings calls across 1 company, most recently for Cytek Biosciences, Inc. on August 5, 2026. Cytek Biosciences, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Cytek Biosciences, Inc. includes William ("Bill") McCombe (CFO), William McCombe (CFO), Chris Williams (COO) and 6 others.
“And based on the market report, the annual placement is between 7,000 to 10,000 within that range.”
“On today's call, I would like to start with a discussion of our performance in the second quarter and first half of 2025, followed by an update on our full year 2025 outlook.”
“On today's call, I will discuss our performance during the first quarter, including factors impacting our business, provide an update on our 2025 outlook, and share details on how we are navigating this dynamic macro environment.”
“On today's call, I will discuss our results for the fourth quarter and full year 2024 and highlight our achievements toward our strategic initiatives to drive sustainable growth and profitability.”
“On today's call, I will provide an overview of our performance in the third quarter and the progress achieved on our strategic initiatives to drive sustainable growth and profitability.”
Start not stated–present
Last confirmed April 28, 2026
Start not stated–present
Last confirmed April 28, 2026
Medical Devices · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cytek Biosciences, Inc. (CTKB) | Chief Executive Officer and President | $620,000 | $5,120,061 |
| 2024 | Cytek Biosciences, Inc. (CTKB) | Chief Executive Officer and President | $599,083 | $6,084,671 |
| 2023 | Cytek Biosciences, Inc. (CTKB) | Chief Executive Officer and President | $578,000 | $4,939,242 |
| 2022 | Cytek Biosciences, Inc. (CTKB) | Chief Executive Officer and President | $524,435 | $3,914,142 |
| 2021 | Cytek Biosciences, Inc. (CTKB) | Chief Executive Officer and President | $375,131 | $4,818,502 |
| 2020 | Cytek Biosciences, Inc. (CTKB) | President and Chief Executive Officer | $241,487 | $422,221 |
